Clinical analysis of 215 consecutive cases with fever of unknown origin
By Y. Zhai, Xin Chen, Xin Liu, Zhi-qiang Zhang, H. Xiao, Gang Liu. Medicine, 2018
3,909 citations recorded by the source corpus.
Abstract Fever of unknown origin (FUO) is a frequently observed phenomenon in clinical practice. The present study was aimed to investigate potential causes of FUO, thereby improving clinical diagnosis of this disorder. In this retrospective study, clinical data were collected from 215 patients who were diagnosed with FUO between January 2009 and December 2010, and an 18 to 36 months follow-up visit was also performed for these patients. Among these FUO cases, the most common causes of the disease were infectious diseases (IDs) (42.3%), followed by connective tissue diseases (CTDs) (32.1%), miscellaneous (Mi) (10.7%) and neoplasm (N) (6.5%), while the causes for the other 18 cases (8.4%) were still unknown. The most common types of ID, CTD, and N were tuberculosis (16/91, 17.6%), adult onset Still disease (AOSD) (37/69, 53.6%) and non-Hodgkin lymphoma (6/14, 42.9%), respectively. IDs still represent the most common causes of FUO. Regularly intermittent fever with urinary infections and irregularly intermittent fever with infective endocarditis may be regarded as some signs in clinical diagnosis of FUO.
Subfields: Emergency Medicine, Molecular Biology, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/b83833f67e61b7f282ba1b03a613ba8643222a21
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- E. Wherry
- D. Mathew
- S. Apostolidis
- Wenzhao Meng
- L. Kuri-Cervantes
- E. M. Anderson
- Aaron M. Rosenfeld
- A. Pattekar
Citations in the corpus
- Small molecule metabolites: discovery of biomarkers and therapeutic targets (2023, background): “Furthermore, metabolite profiles also showed that asparagine synthesis was increased and associated to poor prognosis for female colorectal cancer patients.(581)”
- Comprehensive mapping of immune perturbations associated with severe COVID-19 (2020, background): “Days since onset of symptoms 27 (17-32) 9 (1-16) 9 (1-25)”